Filing Details
- Accession Number:
- 0001490978-23-000004
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-02-03 16:16:55
- Reporting Period:
- 2023-02-02
- Accepted Time:
- 2023-02-03 16:16:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1490978 | Schrodinger Inc. | SDGR | Pharmaceutical Preparations (2834) | 954284541 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1797777 | Yvonne Tran | C/O Schrodinger, Inc., 1540 Broadway, 24Th Floor New York NY 10036 | Evp & Chief Legal Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-02-02 | 11,731 | $2.92 | 16,862 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2023-02-02 | 13,269 | $3.07 | 30,131 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-02-02 | 25,000 | $27.26 | 5,131 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2023-02-02 | 11,731 | $2.92 | 11,731 | $2.92 |
| Common Stock | Stock Option (right to buy) | Disposition | 2023-02-02 | 13,269 | $3.07 | 13,269 | $3.07 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2027-06-01 | No | 4 | M | Direct | |
| 108 | 2026-05-10 | No | 4 | M | Direct |
Footnotes
- These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 8, 2022.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.00 to $27.61, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote(2) of this Form 4.
- The option was granted on June 1, 2017 and is fully vested.
- The option was granted on May 11, 2016 and is fully vested.
Billionaire Hedge Funds
